MODULE 3

Comprehensive Risk Factor Management in People with Diabetes:
What Cardiologists Need to Know





Self-Assessment Program

Step 1: Watch the video

Step 2: Test your knowledge

Step 3: Complete the evaluation form

Step 4: Receive your certificate





X FACULTY

Chair:

Lawrence A. Leiter, MD, FRCPC, FACP, FACE, FAHA, FACC

Endocrinologist, St. Michael’s Hospital
Professor of Medicine and Nutritional Sciences,
University of Toronto
Toronto, ON, Canada



 

Jean C. Grégoire, MD, FRCP(C), FCCS, FACC, FACP

Interventional Cardiologist, Institut de cardiologie de Montréal
Associate Professor, Université de Montréal
Montreal, QC, Canada



 

Irene Hramiak, MD, FRCP(C), MACP

Endocrinologist, St. Joseph’s Health Care
Professor of Medicine, Schulich School of Medicine & Dentistry, Western University
London, ON, Canada



X COMPLETE BIO

Lawrence A. Leiter

MD, FRCPC, FACP, FACE, FAHA, FACC

Endocrinologist, St. Michael’s Hospital
Professor of Medicine and Nutritional Sciences,
University of Toronto
Toronto, ON, Canada


Dr. Lawrence A. Leiter is Director of the Lipid Clinic; Associate Director of the Clinical Nutrition and Risk Factor Modification Centre; and Associate Scientist, Li Ka Shing Knowledge Institute at St. Michael’s Hospital in Toronto where he was also the Head of the Division of Endocrinology and Metabolism from 2000-2010. He is a Professor in the Departments of Medicine and Nutritional Sciences at the University of Toronto.

Dr. Leiter has several research interests including clinical trials on the prevention of atherosclerosis, especially in diabetes, and the dietary and pharmacologic treatment of diabetes mellitus, hyperlipidemia, hypertension, and obesity. He has over 750 publications in peer-reviewed journals. He was an investigator in many of the landmark diabetes trials including the DCCT, ACCORD, and ADVANCE and is on the Executive/Steering Committees of many ongoing outcome trials in both the diabetes and lipid areas. In 2018, 2019, and 2020 he was a Clarivate Analytics Top 1% Highly Cited Researcher.

Dr. Leiter is a Past-President of the Canadian Society of Endocrinology & Metabolism (CSEM) and a past Chair of the Clinical and Scientific Section of the Canadian Diabetes Association (CDA). He has been involved in many national and international committees and consensus conferences including those of the International Diabetes Federation, CDA, Canadian Hypertension Education Program (CHEP), Canadian Cardiovascular Society (Dyslipidemia), and Obesity Canada. He is an Associate Editor of the journal Diabetes Care.

For his work, he has received a number of awards including the CDA Frederick G. Banting Award and the American Diabetes Association Charles H Best Award (awarded to DCCT investigators), both for Distinguished Service, the 2005 CSEM Educator of the Year Award, and the 2006 CDA Gerald S. Wong Award in recognition of significant contributions to the diabetes community. He was the inaugural winner of the St. Michael’s Hospital Complete Physician Award in 2009. He is also the 2016 recipient of both the CDA Lifetime Achievement Award for Research Excellence and the CSEM Robert Volpe Distinguished Service Award. In 2019 was elected as a Fellow of the Canadian Academy of Health Sciences.

X COMPLETE BIO

Jean C. Grégoire

MD, FRCP(C), FCCS, FACC, FACP

Interventional Cardiologist, Institut de cardiologie de Montréal
Associate Professor, Université de Montréal
Montreal, QC, Canada
 


Dr. Jean C. Grégoire received his MD from the University of Montréal in 1985. He performed his residency in Internal Medicine and Cardiology in 1990 at the same University. He completed training in interventional cardiology at the Quebec Heart Institute, followed by two years of animal model study of coronary restenosis after angioplasty and endothelial dysfunction at the Mayo Clinic, Rochester, Minnesota.

He is an Associate Clinical Professor at the University of Montreal and works in the Interventional Cardiology Service, Coronary Care Unit, and in clinical research at the Montréal Heart Institute. He is the author of several book chapters and scientific publications. He is a former co-chair of the Canadian Dyslipidemia Guideline (2012 and 2016) and current member of the primary committee of the Lipid and Hypertension Canada guidelines. His principal research interests include the role of oxidative stress and inflammation in atherosclerosis and endothelial dysfunction, atherosclerotic plaque imaging, dyslipidemia, diabetes, hypertension and acute coronary syndrome.

X COMPLETE BIO

Irene Hramiak

MD, FRCP(C), MACP

Endocrinologist, St. Joseph’s Health Care
Professor of Medicine, Schulich School of Medicine & Dentistry, Western University
London, ON, Canada
 


Irene M. Hramiak, MD, FRCP(C), MACP is a Professor of Medicine, Western University, London, ON. She is the current Department of Medicine Site Chief at St. Joseph’s Hospital. Dr. Hramiak practices Endocrinology at St. Joseph’s Hospital in London, Ontario, with a strong clinical interest in Type 1 and Type 2 diabetes mellitus. Dr. Hramiak has held peer reviewed funding from JDRF, CDA, and the NIH since 1983; she was a co-investigator in the DCCT (1983-2000), for which she was awarded the Charles H. Best Award for distinguished service by the American Diabetes Association in 1993. In 2016, she was awarded the Canadian Diabetes Association’s Gerald S Wong Service Award. She has been a Principle Investigator in many cardiovascular outcome trials in Type 2 diabetes mellitus, including: ACCORD, ORIGIN, TECOS, LEADER, SUSTAIN, REWIND, and DECLARE-TIMI 58. Dr. Hramiak was the Principle Investigator at Western University for the JDRF Ontario trial network. She has been a Principle Investigator for REMOVAL and other trials investigating benefits of new therapies in Type 1 Diabetes. Dr. Hramiak has been recognized by ACP with a Mastership for Academic Excellence in 2020. Western University has awarded her the Alumni of Distinction Award in 2021. Dr. Hramiak serves as an external advisor to many groups and pharmaceutical companies with regards to diabetes and obesity.


X LEARNING OBJECTIVES

After completing this module, clinicians and other healthcare professionals will be better able to:

  • Describe the key components of comprehensive risk factor management in people with diabetes
  • Implement newly updated CCS guideline recommendations for the management of dyslipidemia
  • Discuss new and emerging therapies for reducing CV risk in people with diabetes
X ACCREDITATION

This event is an Accredited Self-Assessment Program under Section 3 as defined by the Royal College of Physicians & Surgeons of Canada for the Maintenance of Certification program and has been approved by the Canadian Cardiovascular Society. This program was co-developed with the Canadian Cardiovascular Society and was planned to achieve scientific integrity, objectivity, and balance. You may claim a maximum of 2 hours (credits are automatically calculated).

X DISCLOSURES

This program was made possible through an educational grant from AstraZeneca, Bayer Canada, Boehringer Ingelheim, Lilly Canada, Janssen, HLS Therapeutics Inc., Novartis & Novo Nordisk.